Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  OpGen, Inc.    OPGN

OPGEN, INC.

(OPGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

OPGEN : Other Events (form 8-K/A)

share with twitter share with LinkedIn share with facebook
08/12/2020 | 06:24pm EDT

Item 8.01 Other Events.

On August 9, 2020, OpGen, Inc. issued a press release relating to OpGen's strategic co-promotion relationship with Menarini Silicon Biosystems. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

© Edgar Online, source Glimpses


share with twitter share with LinkedIn share with facebook
All news about OPGEN, INC.
07:31aOPGEN : Announces Award of German Government Grant Funding to its Subsidiary Cur..
AQ
07:31aOpGen Announces Award of German Government Grant Funding to its Subsidiary Cu..
GL
10/27OPGEN : Corporate Presentation (PDF)
PU
10/15OPGEN INC : Results of Operations and Financial Condition (form 8-K)
AQ
10/15OPGEN : Provides Business and Pipeline Update and Announces Preliminary Unaudite..
AQ
10/15OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudit..
GL
10/13OPGEN : Issues Formal Response to FDA's Requests for Additional Information and ..
AQ
10/13OpGen Issues Formal Response to FDA's Requests for Additional Information and..
GL
10/06OPGEN : Corporate Presentation (PDF)
PU
10/05OpGen Group Company Ares Genetics Wins Austrian Digitization Award for ares-g..
GL
More news
Financials (USD)
Sales 2020 4,29 M - -
Net income 2020 -24,7 M - -
Net Debt 2020 - - -
P/E ratio 2020 -1,39x
Yield 2020 -
Capitalization 44,2 M 44,2 M -
Capi. / Sales 2020 10,3x
Capi. / Sales 2021 3,97x
Nbr of Employees 39
Free-Float 99,9%
Chart OPGEN, INC.
Duration : Period :
OpGen, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPGEN, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 5,00 $
Last Close Price 2,24 $
Spread / Highest target 123%
Spread / Average Target 123%
Spread / Lowest Target 123%
EPS Revisions
Managers
NameTitle
Oliver Schacht Chief Executive Officer & Director
Bill E. Rhodes Non-Executive Chairman
Johannes Bacher Chief Operating Officer
Timothy C. Dec CFO, Secretary & Chief Accounting Officer
Vadim Sapiro Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
OPGEN, INC.98.23%44
LONZA GROUP AG63.59%47 362
SEAGEN INC.72.34%34 263
IQVIA HOLDINGS INC.3.00%30 511
CELLTRION, INC.32.04%28 321
MODERNA, INC.261.30%27 885